News

Biopharma companies are investing in field reimbursement staff to reduce patient barriers to therapy by guiding prescribing physicians through specialty therapy access and adherence challenges

Company pitches a mfr-payer-provider-patient collaboration for drug pricing

TransCelerate opens up its network to qualified researchers; Oracle has a new platform

SensiWatch Platform includes analytics and APIs for integrating supply-chain information

Trinity Life Sciences offers a way to measure changing physician practices during the pandemic

Acquisitions jump BMS and Takeda into Top 10; Amgen and Gilead fall out

Also: more innovative cold-chain actions during the Covid-19 pandemic

1.3-million sq. ft to be added in the US and Europe

Guidance for companies starting out on the commercialization path

Extension of the company’s Pathways program seeks to offer a richer and deeper patient interaction

Position highlights the move toward more at-home services

Guidance for companies starting out on the commercialization path

Use of an eBV system can save months of re-verification work and >$100,000 in operational costs

Industry consortium is poised to manage pharma supply-chain interoperability governance

Chain of identity, chain of custody are high priorities for autologous therapies

Service can be multimodal and multi-provider, and is not device-dependent

Pharma marketing will have to adjust to a new reality

The PBMs’ new trend toward controlling the flow of funds for patient support is raising questions

A laudable goal is being addressed by unusual means, including taxpayer dollars

Former J&J executive will be the organization’s third-ever leader

California researchers needed to find a way to collaborate with their counterparts in Hong Kong

Trump administration goal: ‘substantial quantities of a safe and effective vaccine available for Americans by January 2021’

Quarles & Brady garners an innovative distinction

More packaging vendors are offering ‘curbside recyclable’ containers

Reasons for, and actions to take, when switching hub service providers

Milken Institute survey finds nearly 300 therapies and vaccines

Strains are showing in drug supplies consumed in treating infected patients